Fund
Sound Bioventures
Sound Bioventures led the round of Altay Therapeutics (37 M$, Series A) on 14 October 2026. 3 health rounds logged by Bolus since September 2026, 1 of them as lead.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 1
- New entries
- 1
- Follow ons
- 1
- Latest operation
- 14 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 14 Oct | United States, Biotech | Series A | 37 M$ | Lead |
| 30 Sept | Sweden, Biotech | Series B | 62,5 M€ | Existing investor |
| 29 Sept | Denmark, Biotech | Series A | 67,5 M€ | Participant |
Co investors 17 funds crossed
- Innovestor Life Science 2 operations
- Ljungström family office 2 operations
- Novo Holdings 2 operations
- Pappas Capital 2 operations
- Biogen New Ventures 1 operation
- Catalyze Capital 1 operation
- EIFO 1 operation
- Flerie 1 operation
- Fountain Healthcare Partners 1 operation
- Global BioAccess Fund 1 operation
- HealthCap 1 operation
- Helsinn 1 operation
- Industrifonden 1 operation
- LLD Nybohov Invest AB 1 operation
- Mission BioCapital 1 operation
- Modi Ventures 1 operation
- Pureos Bioventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, Sweden, Denmark.